Sector ratings MBX Biosciences, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 02:33:11 17/07/26 am AEST			5-day change	1st Jan Change
59.76 ^USD	-1.52%		-9.01%	+89.57%

14/07	MBX Biosciences Appoints Steve Hoerter as CEO; Kent Hawryluk Steps Down	MT
14/07	MBX Biosciences, Inc. Announces CEO Changes, Effective July 13, 2026	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation
MBX BIOSCIENCES, INC.	2.89B	-	BBB	-	-	-
LONZA GROUP AG	50.35B		AAA
REVOLUTION MEDICINES, INC.	39.21B	-	B	-		-
IQVIA HOLDINGS INC.	34.52B		AAA
BEONE MEDICINES AG	34.6B		-
CELLTRION, INC.	27.05B		A
ASCENDIS PHARMA A/S	16.68B	-	-	-		-
MEDPACE HOLDINGS, INC.	15.11B		BBB
EUROFINS SCIENTIFIC SE	13.85B		AA
ICON PUBLIC LIMITED COMPANY	13.18B		AAA
ABIVAX	11.81B	-	BBB	-		-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	10.99B		AA
BIO-TECHNE CORPORATION	11.14B		AA
TEMPUS AI, INC.	10.28B		A			-
APOGEE THERAPEUTICS, INC.	10.06B	-	B	-		-
KYMERA THERAPEUTICS, INC.	9.39B	-	BBB	-		-
PHARMARON BEIJING CO., LTD.	9.94B		AA
PRAXIS PRECISION MEDICINES, INC.	8.88B	-	B	-		-
IONIS PHARMACEUTICALS, INC.	9.04B	-	A	-		-
ALKERMES PLC	8.66B		A
Average	17.38B		A
Weighted average by Cap.			A